NCT07268534Phase 2Not yet recruiting
Biologics in Folliculitis Decalvans : an Adaptative Trial Research
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 2
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Participants (registry)
- 120
- Start
- April 2026 (planned)
- Primary completion
- November 2029 (planned)
- Study completion
- April 2030 (planned)
- Last registry update
- December 2025
- Countries
- —
Conditions studied: Folliculitis Decalvans (FD)
Interventions: Adalimumab, Ustekinumab, Baricitinib
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.